Keyphrases
HPV16
100%
High-risk Human Papillomavirus (HR-HPV)
100%
Cervical Cancer
100%
Clinical Evaluation
100%
Atypical Squamous Cells of Undetermined Significance (ASC-US)
100%
Human Detection
100%
Aptima
100%
Aptima HPV
87%
High-risk HPV
50%
HPV Genotyping
50%
HPV Positive
37%
Genotyping Assay
37%
CIN2+
37%
Genotype
12%
Human Papillomavirus Testing
12%
E7 Oncogene
12%
Cervical Cancer Incidence
12%
Messenger RNA (mRNA)
12%
Carcinoma in Situ
12%
Human Papillomavirus Negative
12%
Cytological Diagnosis
12%
Papanicolaou
12%
Clinical Performance
12%
Cervical Intraepithelial Neoplasia Grade 2
12%
HPV Negative
12%
Cancer Risk Stratification
12%
RNA Test
12%
Medicine and Dentistry
Wart Virus
100%
Human Papillomavirus Type 18
100%
Human Papillomavirus Type 16
100%
Clinical Trial
100%
Cytotechnology
100%
Precancerous Condition
100%
Human Papillomavirus Type 45
100%
Squamous Cell
100%
Cervical Intraepithelial Neoplasia
20%
Cervical Cancer
20%
Cancer Risk
20%
Clinical Study
20%
Risk Stratification
20%
Oncogene
20%
Adenocarcinoma in Situ
20%
Immunology and Microbiology
Wart Virus
100%
Human Papillomavirus Type 16
100%
Human Papillomavirus Type 18
100%
Squamous Cell
100%
Human Papillomavirus Type 45
100%
Oncogene
20%